Heron Therapeutics
Stock Forecast, Prediction & Price Target
Heron Therapeutics Financial Estimates
Heron Therapeutics Revenue Estimates
Heron Therapeutics EBITDA Estimates
Heron Therapeutics Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | 12/31/2027 | 12/31/2028 |
Revenue
% change YoY
| $86.34M N/A | $107.67M 24.69% | $127.04M 17.99% | Avg: $177.92M Low: $176.64M High: $179.26M avg. 40.04% | Avg: $216.53M Low: $212.36M High: $222.20M avg. 21.69% | Avg: $244.4M Low: $239.69M High: $250.80M avg. 12.86% | Avg: $288.76M Low: $283.21M High: $296.33M avg. 18.15% |
Net Income
% change YoY
| $-217.66M N/A | $-134.51M 38.19% | $-110.55M 17.80% | Avg: $1.41M Low: $-6.90M High: $8.28M avg. 101.28% | Avg: $39.5M Low: $31.77M High: $34.53M avg. 2688.22% | Avg: $45.58M Low: $44.44M High: $47.13M avg. 15.40% | Avg: $62.85M Low: $61.27M High: $64.99M avg. 37.87% |
EBITDA
% change YoY
| $-217.82M N/A | $-174.65M 19.81% | $-103.79M 40.57% | Avg: $-172.51M Low: $-173.81M High: $-171.26M avg. -66.20% | Avg: $-209.94M Low: $-215.44M High: $-205.90M avg. -21.69% | Avg: $-236.96M Low: $-243.17M High: $-232.40M avg. -12.86% | Avg: $-279.98M Low: $-287.31M High: $-274.59M avg. -18.15% |
EPS
% change YoY
| -$2.21 N/A | -$1.24 43.89% | -$0.8 35.48% | Avg: $0.01 Low: -$0.05 High: $0.06 avg. 100.83% | Avg: $0.24 Low: $0.23 High: $0.25 avg. 3498.20% | Avg: $0.33 Low: $0.32 High: $0.34 avg. 37.50% | Avg: $0.46 Low: $0.44 High: $0.47 avg. 37.87% |
Operating Expenses
% change YoY
| $258.15M N/A | $227.45M -11.89% | $172.55M -24.13% | Avg: $198.50M Low: $197.07M High: $200.00M avg. 15.03% | Avg: $241.57M Low: $236.92M High: $247.91M avg. 21.69% | Avg: $272.66M Low: $267.42M High: $279.81M avg. 12.86% | Avg: $322.16M Low: $315.96M High: $330.61M avg. 18.15% |
FAQ
What is Heron Therapeutics stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 710.69% in 2025-2028.
We have gathered data from 3 analysts. Their low estimate is -6.90M, average is 1.41M and high is 8.28M.
What is Heron Therapeutics stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 23.19% in 2025-2028.
We have gathered data from 3 analysts. Their low revenue estimate is $176.64M, average is $177.92M and high is $179.26M.
What is Heron Therapeutics stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 918.60% in 2025-2028.
We have gathered data from 3 analysts. Their low earnings per share estimate is -$0.05, average is $0.01 and high is $0.06.
What is the best performing analyst?
In the last twelve months analysts have been covering Heron Therapeutics stock. The most successful analyst is Carl Byrnes.